The Oncosearch | Oncotarget

Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Childrenâ€™s Oncology Group report Research Paper

Xin Long, Robert B. Gerbing, Todd A. Alonzo, Michele S. Redell

Published Sep 28, 2017 · Vol. 8, No. 52 · pp. 90037-90049

DNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma Research Paper

Takeshi Otsubo, Kazuhiko Yamada, Teruki Hagiwara, Kenshiro Oshima, Kei Iida, Koro Nishikata, Tetsuro Toyoda, Toru Igari, Kyoko Nohara, Satoshi Yamashita, Masahira Hattori, Taeko Dohi, Yuki I. Kawamura

Published Sep 28, 2017 · Vol. 8, No. 48 · pp. 84434-84448

The relationship between DNA methylation and Reprimo gene expression in gastric cancer cells Research Paper

Junzhong Lai, Hanze Wang, Qianping Luo, Shanlu Huang, Shujin Lin, Yansong Zheng, Qi Chen

Published Sep 28, 2017 · Vol. 8, No. 65 · pp. 108610-108623

Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma Research Paper

Joshua Jiawei Zhou, Yuanshen Huang, Xue Zhang, Yabin Cheng, Liren Tang, Xiaodong Ma

Published Sep 27, 2017 · Vol. 8, No. 62 · pp. 105081-105092

37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers in vitro Research Paper

Tyrone C. Otgaar, Eloise Ferreira, Sibusiso Malindisa, Martin Bernert, Boitelo T. Letsolo, Stefan F.T. Weiss

Published Sep 27, 2017 · Vol. 8, No. 49 · pp. 86646-86656

PD-L1 promoter methylation mediates the resistance response to anti-PD-1 therapy in NSCLC patients with EGFR-TKI resistance Research Paper

Yan Zhang, Cheng Xiang, Yuling Wang, Yuanyuan Duan, Ci Liu, Yajing Zhang

Published Sep 27, 2017 · Vol. 8, No. 60 · pp. 101535-101544

Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept Research Paper

AurÃ©lien Voissiere, ValÃ©rie Weber, Yvain Gerard, FranÃ§oise RÃ©dini, Florian Raes, Jean-Michel Chezal, FranÃ§oise Degoul, Caroline Peyrode, Elisabeth Miot-Noirault

Published Sep 27, 2017 · Vol. 8, No. 56 · pp. 95824-95840

Proteogenomic analysis prioritises functional single nucleotide variants in cancer samples Research Paper

Shiyong Ma, Ranjeeta Menon, Rebecca C. Poulos, Jason W.H. Wong

Published Sep 27, 2017 · Vol. 8, No. 56 · pp. 95841-95852

MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells Research Paper

Meike Kaehler, Johanna Ruemenapp, Daniel Gonnermann, Inga Nagel, Oliver Bruhn, Sierk Haenisch, Ole Ammerpohl, Daniela Wesch, Ingolf Cascorbi, Henrike Bruckmueller

Published Sep 26, 2017 · Vol. 8, No. 54 · pp. 92018-92031

Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon Research Paper

Yi-Dong Hong, Jian Zhang, Ming Zhuang, Wei Li, Puy-Uan Wu, Ru-Tian Li, Nan Hu, Bao-Xiang Bian, Zi-Yan Song, Feng-Lei Wu

Published Sep 26, 2017 · Vol. 8, No. 70 · pp. 114495-114505

PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation Research Paper

Zhi-Xian Yin, Wei Hang, Gang Liu, Yi-Shu Wang, Xiang-Feng Shen, Qian-Hui Sun, Dong-Dong Li, Yong-Ping Jian, Yang-He Zhang, Cheng-Shi Quan, Qinghua Zeng, Yu-Lin Li, Rui-Xun Zhao, Qiang Ding, Zhi-Xiang Xu

Published Sep 26, 2017 · Vol. 9, No. 2 · pp. 1885-1897

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study Clinical Research Papers

Yousef Zakharia, Varun Monga, Umang Swami, Aaron D. Bossler, Michele Freesmeier, Melanie Frees, Mirza Khan, Noah Frydenlund, Rithu Srikantha, Marion Vanneste, Michael Henry, Mohammed Milhem

Published Sep 26, 2017 · Vol. 8, No. 51 · pp. 89182-89193

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF^V600E Priority Research Paper

Zeus A. Antonello, Nancy Hsu, Manoj Bhasin, Giovanni Roti, Mukta Joshi, Paul Van Hummelen, Emily Ye, Agnes S. Lo, S. Ananth Karumanchi, Christine R. Bryke, Carmelo Nucera

Published Sep 24, 2017 · Vol. 8, No. 49 · pp. 84743-84760

Inference of time-delayed gene regulatory networks based on dynamic Bayesian network hybrid learning method Research Paper

Bin Yu, Jia-Meng Xu, Shan Li, Cheng Chen, Rui-Xin Chen, Lei Wang, Yan Zhang, Ming-Hui Wang

Published Sep 23, 2017 · Vol. 8, No. 46 · pp. 80373-80392

Thymine DNA Glycosylase (TDG) is involved in the pathogenesis of intestinal tumors with reduced APC expression Research Paper

Jinfei Xu, Salvatore Cortellino, Rossella Tricarico, Wen-Chi Chang, Gabrielle Scher, Karthik Devarajan, Michael Slifker, Robert Moore, Maria Rosaria Bassi, Elena Caretti, Margie Clapper, Harry Cooper, Alfonso Bellacosa

Published Sep 23, 2017 · Vol. 8, No. 52 · pp. 89988-89997

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy Research Paper

Ji-Yeon Kim, Donghyun Park, Dae-Soon Son, Seok Jin Nam, Seok Won Kim, Hae Hyun Jung, Yeon Jeong Kim, Gahee Park, Woong-Yang Park, Jeong Eon Lee, Yeon Hee Park

Published Sep 23, 2017 · Vol. 8, No. 49 · pp. 86423-86434

Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma Research Paper

Yu Ri Kim, Soo-Jeong Kim, June-Won Cheong, Haerim Chung, Ji Eun Jang, Yundeok Kim, Woo-Ick Yang, Yoo Hong Min, Jin Seok Kim

Published Sep 23, 2017 · Vol. 8, No. 54 · pp. 92312-92323

TET1 inhibits cell proliferation by inducing RASSF5 expression Research Paper

Bo-Tai Li, Chao Yu, Ying Xu, Sheng-Bing Liu, Heng-Yu Fan, Wei-Wei Pan

Published Sep 23, 2017 · Vol. 8, No. 49 · pp. 86395-86409

Cisplatin radiosensitizes radioresistant human mesenchymal stem cells Research Paper

Alexander RÃ¼hle, Ramon Lopez Perez, Christin Glowa, Klaus-Josef Weber, Anthony D. Ho, JÃ¼rgen Debus, Rainer Saffrich, Peter E. Huber, Nils H. Nicolay

Published Sep 23, 2017 · Vol. 8, No. 50 · pp. 87809-87820

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer Research Paper

Sanaz Taromi, Florentine Lewens, Ruza Arsenic, Dagmar Sedding, JÃ¶rg SÃ¤nger, Almut Kunze, Markus MÃ¶bs, Joana Benecke, Helma Freitag, Friederike Christen, Daniel Kaemmerer, Amelie Lupp, Mareike Heilmann, Hedwig Lammert, Claus-Peter Schneider, Karen Richter, Michael Hummel, Britta Siegmund, Meike Burger, Franziska Briest, Patricia Grabowski

Published Sep 23, 2017 · Vol. 8, No. 57 · pp. 97061-97078

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Childrenâ€™s Oncology Group report Research Paper

DNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma Research Paper

The relationship between DNA methylation and Reprimo gene expression in gastric cancer cells Research Paper

Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma Research Paper

37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers in vitro Research Paper

PD-L1 promoter methylation mediates the resistance response to anti-PD-1 therapy in NSCLC patients with EGFR-TKI resistance Research Paper

Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept Research Paper

Proteogenomic analysis prioritises functional single nucleotide variants in cancer samples Research Paper

MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells Research Paper

Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon Research Paper

PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation Research Paper

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study Clinical Research Papers

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF^V600E Priority Research Paper

Inference of time-delayed gene regulatory networks based on dynamic Bayesian network hybrid learning method Research Paper

Thymine DNA Glycosylase (TDG) is involved in the pathogenesis of intestinal tumors with reduced APC expression Research Paper

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy Research Paper

Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma Research Paper

TET1 inhibits cell proliferation by inducing RASSF5 expression Research Paper

Cisplatin radiosensitizes radioresistant human mesenchymal stem cells Research Paper

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Childrenâ€™s Oncology Group report Research Paper

DNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma Research Paper

The relationship between DNA methylation and Reprimo gene expression in gastric cancer cells Research Paper

Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma Research Paper

37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers in vitro Research Paper

PD-L1 promoter methylation mediates the resistance response to anti-PD-1 therapy in NSCLC patients with EGFR-TKI resistance Research Paper

Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept Research Paper

Proteogenomic analysis prioritises functional single nucleotide variants in cancer samples Research Paper

MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells Research Paper

Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon Research Paper

PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation Research Paper

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study Clinical Research Papers

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E Priority Research Paper

Inference of time-delayed gene regulatory networks based on dynamic Bayesian network hybrid learning method Research Paper

Thymine DNA Glycosylase (TDG) is involved in the pathogenesis of intestinal tumors with reduced APC expression Research Paper

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy Research Paper

Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma Research Paper

TET1 inhibits cell proliferation by inducing RASSF5 expression Research Paper

Cisplatin radiosensitizes radioresistant human mesenchymal stem cells Research Paper

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer Research Paper

Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF^V600E Priority Research Paper